Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.22.9813

Evidence Based Analysis of Cisplatin for Treating Patients with Cutaneous Squamous Cell Carcinoma  

Shao, Xiao-Hong (Department of Dermatology, The First Affiliated Hospital of Wenzhou Medical University)
Xu, Yun-Sheng (Department of Dermatology, The First Affiliated Hospital of Wenzhou Medical University)
Zhang, Xue-Qi (Department of Dermatology, The First Affiliated Hospital of Wenzhou Medical University)
Li, Wen-Feng (Department of Radiotherapy, The First Affiliated Hospital of Wenzhou Medical University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.22, 2014 , pp. 9813-9815 More about this Journal
Abstract
Background: This analysis was conducted to evaluate the efficacy and safety of cisplatin based chemotherapy for treating patients with cutaneous squamous cell carcinoma. Methods: Clinical studies evaluating the efficacy and safety of cisplatin based regimens on response and safety for patients with cutaneous squamous cell carcinoma were identified using a predefined search strategy. Pooled response rates (RR) of treatment were calculated. Results: In cisplatin based regimens, 4 clinical studies which including 50 patients with advanced cutaneous squamous cell carcinoma were considered eligible for inclusion. Regimens included cisplatin, doxorubicin, or vindesine. Pooled analysis suggested that, in all patients, the pooled RR was 60% (30/50) in cisplatin based regimens. Nausea and vomiting were the main side effects. No grade III or IV renal or liver toxicity were observed. No treatment related death occurred with the cisplatin based treatments. Conclusion: Evidence based analysis suggests that cisplatin based regimens are associated with a good response rate and acceptable toxicity for treating patients with cutaneous squamous cell carcinoma.
Keywords
Cutaneous SCC; cisplatin-based therapy; toxicity; response rate;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Lippman SM, Parkinson DR, Itri LM et al (1992). 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst, 84, 235-41.   DOI
2 Merimsky O, Neudorfer M, Spitzer E, et al (1992). Salvage cisplatin and adriamycin for advanced or recurrent basal or squamous cell carcinoma of the face. Anticancer Drugs, 3, 481-4.   DOI
3 Miller AB, Hoogstraten B, Staquet M, et al (1981). Reporting results of cancer treatment. Cancer, 47, 207-14.   DOI   ScienceOn
4 Miller DL, Weinstock MA (1994). Nonmelanoma skin cancer in the United States: Incidence. J Am Acad Dermatol, 30, 774-8.   DOI   ScienceOn
5 Minton TJ (2008). Contemporary Mohs surgery applications. Curr Opin Otolaryngol Head Neck Surg, 16, 376-80.   DOI
6 Mohs F (1978). Chemosurgery: Microscopically Controlled Surgery for Skin Cancer. Springfield, IL: Charles C. Thomas, 153-64.
7 Nakamura K, Okuyama R, Saida T, et al (2013). Platinum and anthracycline therapy for advanced cutaneous squamous cell carcinoma. Int J Clin Oncol, 18, 506-9.   DOI
8 Sadek H, Azli N, Wendling JL, et al (1990). Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin. Cancer, 66, 1692-6.   DOI
9 Shin DM, Glisson BS, Khuri FR, et al (2002). Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. J Clin Oncol, 20, 364-70.   DOI
10 Veness MJ, Morgan GJ, Palme CE, et al (2005). Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: Combined treatment should be considered best practice. Laryngoscope, 115, 870-5.   DOI
11 Wang SQ, Li J, Tang WR, et al (2013). Note of clarification of data in the meta-analysis of XPC 939A>C and 499C>T polymorphisms in skin cancer. Asian Pac J Cancer Prev, 14, 2687-8.   과학기술학회마을   DOI
12 Wu Q, Zhao YB, Sun ZH, et al (2013). Clinical application of endoscopic inguinal lymph node resection after lipolysis and liposuction for vulvar cancer. Asian Pac J Cancer Prev, 14, 7121-6.   과학기술학회마을   DOI   ScienceOn
13 Alam M, Ratner D (2001). Cutaneous squamous-cell carcinoma. N Engl J Med, 344, 975-83.   DOI   ScienceOn
14 Bleomycin in advanced squamous cell carcinoma: A random controlled trial, et al (1976). Report of Medical Research Council Working Party on Bleomycin. Br Med J, 1, 188-90.   DOI
15 Clayman GL, Lee JJ, Holsinger FC, et al (2005). Mortality risk from squamous cell skin cancer. J Clin Oncol, 23, 759-65.   DOI
16 Cranmer LD, Engelhardt C, Morgan SS, et al (2010). Treatment of unresectable and metastatic cutaneous squamous cell carcinoma. Oncologist, 15 1320-8.   DOI
17 Deng QQ, Huang XE, Ye LH, et al (2013). Phase II trial of $Loubo^{(R)}$ (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes. Asian Pac J Cancer Prev, 14, 413-7.   과학기술학회마을   DOI   ScienceOn
18 Fujisawa Y, Umebayashi Y, Ichikawa E, et al (2006). Chemoradiation using lowdose cisplatin and 5-fluorouracil in locally advanced squamous cell carcinoma of the skin: A report of two cases. J Am Acad Dermatol, 55, S81-5.   DOI
19 Goldberg H, Tsalik M, Bernstein Z, et al (1994). Cisplatinbased chemotherapy for advanced basal and squamous cell carcinomas. Harefuah, 127, 217-21.
20 Guthrie TH Jr, McElveen LJ, Porubsky ES, et al (1985). Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin. Cancer, 55, 1629-32.   DOI
21 Guthrie TH Jr, Porubsky ES, Luxenberg MN, et al (1990). Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: Results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol, 8, 342-6.
22 Han A, Ratner D (2007). What is the role of adjuvant radiotherapy in the treatment of cutaneous squamous cell carcinoma with perineural invasion? Cancer, 109, 1053-59.   DOI
23 Hao ZF, Ao JH, Zhang J, et al (2013). ATF3 activates Stat3 phosphorylation through inhibition of p53 expression in skin cancer cells. Asian Pac J Cancer Prev, 14, 7439-44.   과학기술학회마을   DOI
24 Ikegawa S, Saida T, Obayashi H, et al (2013). Cisplatin combination chemotherapy in squamous cell carcinoma and adenoid cystic carcinoma of the skin. J Dermatol, 16, 227-30.
25 Jambusaria-PahlajaniA, Miller CJ, QuonH, et al (2009). Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: A systematic review of outcomes. Dermatol Surg, 35, 574-85.   DOI
26 Joseph MG, Zulueta WP, Kennedy PJ, et al (1992). Squamous cell carcinoma of the skin of the trunk and limbs: The incidence of metastases and their outcome. Aust NZ J Surg, 62, 697-01.   DOI
27 Khansur T, Kennedy A (1991). Cisplatin and 5-fluorouracil for advanced locoregional and metastatic squamous cell carcinoma of the skin. Cancer, 67, 2030-32.   DOI